StockData
Kestra Medical Technologies, Ltd. logo

Kestra Medical Technologies, Ltd. (KMTS) stock

KMTSNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends April 30
Financials through Q1 FY2027, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 14, 2026Score 5/30
$25.10−1.53 (-5.75%)

Close on Nov 20, 2026Market cap $1.50BP/E –Yield –

Kestra Medical Technologies free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

Kestra Medical Technologies's free cash flow for the twelve months ending Jul 31, 2026 was -$122.79M. For fiscal 2026 it was -$116.60M.

Annual free cash flow

PeriodPeriod endValueChange
FY2026Apr 30, 2026-$116.60M–
FY2025Apr 30, 2025-$100.54M–
FY2024Apr 30, 2024-$84.46M–

Quarterly free cash flow

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q1 FY2027CQ2 2026Jul 31, 2026-$40.63M–
Q4 FY2026CQ1 2026Apr 30, 2026-$28.38M–
Q3 FY2026CQ4 2025Jan 31, 2026-$28.16M–
Q2 FY2026CQ3 2025Oct 31, 2025-$25.61M–
Q1 FY2026CQ2 2025Jul 31, 2025-$34.44M–
Q4 FY2025CQ1 2025Apr 30, 2025-$31.45M–
Q3 FY2025CQ4 2024Jan 31, 2025-$22.06M–
Q2 FY2025CQ3 2024Oct 31, 2024-$22.50M–
Q1 FY2025CQ2 2024Jul 31, 2024-$24.54M–

More Kestra Medical Technologies figures

See a number that looks wrong?